Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
PSYCHIATRY	O
Allergies:	O
Bactrim	O
/	O
cephalexin	O
Attending:	O
___	O
Chief	O
Complaint:	O
Depression	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
ECT	O
History	O
of	O
Present	O
Illness:	O
Mr.	O
___	O
is	O
a	O
___	O
year	O
old	O
man	O
with	O
a	O
history	O
of	O
severe	O
agitated	O
psychotic	O
depression	O
and	O
suicide	O
attempt,	O
s/p	O
two	O
unsuccessful	O
ECT	O
trials	O
in	O
the	O
past,	O
who	O
is	O
transferred	O
to	O
___	O
from	O
___	O
for	O
possible	O
ECT	O
after	O
a	O
recent	O
suicide	O
attempt	O
via	O
overdose	O
resulting	O
in	O
unresponsiveness	O
and	O
ICU	O
stay.	O
.	O
He	O
was	O
brought	O
in	O
to	O
the	O
___	O
on	O
___	O
after	O
being	O
found	O
unresponsive	O
by	O
family	O
members	O
earlier	O
that	O
day.	O
He	O
had	O
last	O
been	O
seen	O
in	O
his	O
usual	O
state	O
of	O
health	O
the	O
prior	O
evening.	O
When	O
family	O
found	O
him,	O
he	O
was	O
apparently	O
pulseless,	O
so	O
they	O
initiated	O
CPR	O
and	O
called	O
EMS.	O
When	O
EMS	O
arrived	O
he	O
was	O
significantly	O
hypotensive.	O
He	O
was	O
intubated	O
in	O
the	O
field,	O
and	O
received	O
Narcan	O
in	O
the	O
field	O
without	O
effect.	O
BP	O
on	O
arrival	O
to	O
the	O
ED	O
was	O
54/35.	O
Diagnostic	O
studies	O
performed	O
included	O
CT	O
head	B-Intracranial_haemorrhage
and	O
chest	B-Lower_respiratory_tract_infection
(both	O
unremarkable),	B-Intracranial_haemorrhage
EKG	O
and	O
troponins	O
(normal),	O
and	O
elevated	O
CK	O
thought	O
secondary	O
to	O
rhabdomyolysis.	O
His	O
UTox	O
was	O
positive	O
for	O
benzodiazepines	O
and	O
tricyclics,	O
but	O
per	O
admission	O
note	O
"he	O
does	O
take	O
klonopin	O
as	O
well	O
as	O
trazodone"	O
at	O
home.	O
I	O
spoke	O
with	O
the	O
MD	O
who	O
discharged	O
him	O
___,	O
phone	O
#	O
___	O
who	O
reports	O
that	O
they	O
believe	O
it	O
was	O
a	O
benzodiazepine	O
overdose.	O
Patient	O
himself	O
has	O
no	O
recollection	O
of	O
what	O
pills	O
he	O
took.	O
He	O
was	O
admitted	O
to	O
the	O
ICU	O
and	O
then	O
the	O
medical	O
floor	O
for	O
10	O
days	O
before	O
he	O
could	O
be	O
stabilized	O
and	O
transferred	O
to	O
Psychiatry.	O
On	O
initial	O
psychiatric	O
interview,	O
he	O
was	O
still	O
encephalopathic	O
but	O
this	O
cleared	O
and	O
MMS	O
improved	O
to	O
___.	O
He	O
stated	O
that	O
he	O
took	O
many	O
pills	O
on	O
the	O
date	O
of	O
his	O
admission	O
and	O
the	O
intent	O
was	O
to	O
end	O
his	O
life.	O
He	O
fixated	O
on	O
constipation-related	B-Constipation
pain	O
and	O
asked	O
for	O
enema.	O
.	O
Collateral	O
obtained	O
from	O
his	O
brother	O
___	O
at	O
___	O
revealed	O
that	O
patient	O
had	O
hospital	O
stays	O
at	O
___	O
___	O
ECT	O
in	O
the	O
past,	O
but	O
neither	O
were	O
helpful.	O
Over	O
the	O
past	O
several	O
months,	O
patient	O
endorses	O
a	O
40	O
pound	O
weight	B-Weight_loss
loss	B-Weight_loss
(possibly	O
due	O
to	O
poor	O
eating	O
but	O
he	O
is	O
unsure)	O
from	O
170	O
to	O
130	O
lbs.	O
He	O
reports	O
trying	O
to	O
take	O
Ensure	O
while	O
at	O
___	O
but	O
still	O
could	O
not	O
gain	O
weight.	O
Patient	O
also	O
has	O
a	O
fixation	O
with	O
enemas	O
and	O
has	O
several	O
of	O
them	O
in	O
his	O
apartment.	O
He	O
is	O
apparently	O
convinced	O
that	O
there	O
is	O
always	O
something	O
wrong	O
with	O
him.	O
Per	O
his	O
brother	O
___,	O
the	O
patient	O
also	O
apparently	O
often	O
thinks	O
that	O
he	O
smells	O
and	O
that	O
this	O
is	O
affecting	O
other	O
people.	O
Mr.	O
___	O
tells	O
us	O
today	O
that	O
both	O
of	O
his	O
past	O
suicide	O
attempts	O
were	O
due	O
to	O
frustration	O
with	O
his	O
bowel	O
problems:	O
this	O
last	O
attempt	O
was	O
prompted	O
by	O
receiving	O
an	O
enema	O
at	O
an	O
ED	O
but	O
being	O
unable	O
to	O
figure	O
out	O
how	O
to	O
use	O
it,	O
so	O
he	O
decided	O
to	O
end	O
his	O
life.	O
.	O
Hospital	O
course	O
at	O
___:	O
When	O
he	O
arrived	O
on	O
Psychiatry	O
unit	O
he	O
admitted	O
to	O
___	O
but	O
had	O
no	O
plan;	O
was	O
upset	O
that	O
his	O
attempt	O
had	O
failed.	O
He	O
reported	O
insomnia	O
and	O
weight	B-Weight_loss
loss,	B-Weight_loss
but	O
was	O
observed	O
to	O
sleep	O
well	O
overnight	O
and	O
eat	O
most	O
of	O
his	O
meals.	O
He	O
was	O
started	O
on	O
Risperdal,	O
Effexor	O
and	O
Remeron	O
and	O
uptitrated	O
on	O
all	O
of	O
these	O
in	O
the	O
setting	O
of	O
ongoing	O
psychotic	O
depression,	O
irritability	O
and	O
self-isolation.	O
He	O
complained	O
of	O
insomnia,	O
so	O
was	O
started	O
on	O
Trazodone	O
which	O
was	O
uptitrated.	O
During	O
stay	O
he	O
continued	O
to	O
fixate	O
on	O
his	O
bowel	O
movements	O
in	O
a	O
psychotic	O
manner,	O
convinced	O
he	O
was	O
constipated	B-Constipation
despite	O
frequent	O
formed	O
stools.	O
When	O
asked	O
why	O
he	O
had	O
attempted	O
suicide,	O
he	O
stated	O
that	O
he	O
was	O
frustrated	O
by	O
his	O
abnormal	O
bowel	O
function.	O
Over	O
time	O
he	O
started	O
to	O
deny	O
that	O
he'd	O
had	O
any	O
suicidal	O
thoughts.	O
Other	O
times	O
he	O
seemed	O
more	O
anxious	O
and	O
paranoid,	O
and	O
refused	O
to	O
come	O
out	O
to	O
the	O
dining	O
room	O
for	O
a	O
meal.	O
Per	O
the	O
discharge	O
summary,	O
"Psychologically,	O
the	O
patient	O
was	O
quite	O
nihilistic	O
in	O
his	O
attitude;	O
he	O
was	O
also	O
noted	O
to	O
be	O
somewhat	O
dependent	O
on	O
others	O
and	O
avoidant	O
as	O
well".	O
.	O
Ultimately,	O
with	O
the	O
patient's	O
reluctant	O
consent	O
it	O
was	O
decided	O
to	O
transfer	O
him	O
to	O
___	O
for	O
another	O
trial	O
of	O
ECT.	O
Past	O
Medical	O
History:	O
-	O
History	O
of	O
severe	O
agitated	O
psychotic	O
depression	O
-	O
___:	O
Hospitalized	O
at	O
___	O
for	O
depression	O
exacerbation	O
-	O
___:	O
suicide	O
attempt	O
via	O
OD	O
of	O
Klonopin,	O
Ambien	O
and	O
alcohol,	O
hospitalized	O
again	O
at	O
___	O
-	O
Has	O
h/o	O
two	O
ECT	O
trials:	O
one	O
at	O
___	O
and	O
another	O
at	O
___	O
later	O
in	O
___	O
-	O
Sees	O
a	O
provider	O
at	O
___	O
(___	O
says	O
he	O
has	O
now	O
switched	O
to	O
someone	O
at	O
___	O
Counseling	O
in	O
___	O
-	O
PCP	O
is	O
___	O
(___)	O
.	O
Past	O
Medical	O
History:	O
-	O
Hypertension	O
-	O
COPD	O
-	O
Hyperlipidemia	O
-	O
GERD	O
-	O
Esophageal	O
dysmotility	O
-	O
Anemia	O
-	O
Insomnia	O
(takes	O
___	O
sleep	O
aids)	O
-	O
Recent	O
dx	O
prostatitis	O
-	O
Chronic	O
constipation	B-Constipation
(may	O
be	O
more	O
of	O
a	O
preoccupation	O
with	O
his	O
bowels)	O
-	O
H/O	O
umbilical	O
and	O
inguinal	O
hernia,	O
s/p	O
___	O
laparoscopic	O
inguinal	O
hernia	O
repair	O
with	O
mesh	O
and	O
open	O
umbilical	O
hernia	O
with	O
mesh	O
(___)	O
Social	O
History:	O
___	O
Family	O
History:	O
history	O
of	O
depression	O
in	O
the	O
patient's	O
mother	O
and	O
maternal	O
side	O
of	O
the	O
family.	O
Physical	O
Exam:	O
Neurological:	O
*station	O
and	O
gait:	O
normal	O
narrow	O
based	O
stride	O
and	O
arm	O
swing	O
*tone	O
and	O
strength:	O
normal	O
tone,	O
no	O
cogwheeling/rigidity	O
cranial	O
nerves:	O
PERRL,	O
EOMI,	O
R	O
levator	O
dehiscence,	O
face	O
symmetric,	O
tongue	O
protrudes	O
in	O
midline	O
abnormal	O
movements:	O
fine	O
postural	O
tremor	O
with	O
hands	O
outstretched,	O
no	O
resting	O
tremor,	O
no	O
dystonias/dyskinesias	O
frontal	O
release:	O
NT	O
*Appearance:	O
thin,	O
flat	O
appearing	O
elderly	O
man	O
sitting	O
in	O
chair	O
with	O
few	O
spontaneous	O
movements	O
Behavior:	O
calm,	O
appropriate	O
*Mood	O
and	O
Affect:	O
mood	O
is	O
"fine",	O
affect	O
is	O
flat	O
with	O
restricted	O
range	O
*Thought	O
process:	O
linear,	O
without	O
tangential	O
aspects	O
or	O
loose	O
associations	O
*Thought	O
Content:	O
denies	O
active/passive	O
suicidal	O
or	O
homicidal	O
ideation.	O
States	O
that	O
if	O
he	O
did	O
feel	O
suicidal,	O
he	O
would	O
certainly	O
not	O
act	O
on	O
it	O
in	O
the	O
hospital.	O
Denies	O
visual/auditory	O
or	O
olfactory	O
hallucinations.	O
*Judgment	O
and	O
Insight:	O
poor	O
insight	O
and	O
judgment	O
Cognition:	O
*Attention,	O
*orientation,	O
and	O
executive	O
function:	O
AAOx3,	B-Delirium
attentive	O
on	O
MOYB	O
with	O
digit	O
span	O
of	O
4	O
backward	O
*Memory:	O
registration	O
and	O
recall	O
___	O
*Fund	O
of	O
knowledge:	O
knows	O
current	O
president,	O
but	O
not	O
prior	O
president	O
___	O
Calculations:	O
NT	O
Abstraction:	O
similarity	O
btw	O
apple	O
and	O
orange	O
is	O
both	O
are	O
"round"	O
and	O
"fruits".	O
similarity	O
btw	O
plane	O
and	O
boat	O
is	O
that	O
"both	O
take	O
you	O
places".	O
When	O
asked	O
the	O
meaning	O
of	O
"a	O
rolling	O
stone	O
gathers	O
no	O
moss",	O
he	O
responded	O
"you	O
shouldn't	O
sit	O
still".	O
Visuospatial:	O
grossly	O
intact	O
*Speech:	O
no	O
dysarthria	O
*Language:	O
naming	O
intact	O
to	O
high	O
and	O
low	O
frequency	O
objects	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
GLUCOSE-115*	O
UREA	O
N-24*	O
CREAT-0.8	O
SODIUM-139	O
POTASSIUM-4.1	O
CHLORIDE-102	O
TOTAL	O
CO2-33*	O
ANION	O
GAP-8	O
ALBUMIN-3.5	O
CALCIUM-8.4	O
PHOSPHATE-3.3	O
MAGNESIUM-1.9	O
WBC-7.2	O
RBC-3.81*	O
HGB-12.0*	O
HCT-36.9*	O
MCV-97	O
MCH-31.5	O
MCHC-32.6	O
RDW-14.2	O
NEUTS-59.7	O
___	O
MONOS-7.5	O
EOS-2.5	O
BASOS-0.8	O
ALT-10	O
AST-13	O
AlkPhos-86	O
TotBili-0.2\	O
TSH-2.7	O
HCG-<5	O
RPR-nonreactive	O
CHEST	O
CT	O
W/O	O
CONTRAST	O
___,	O
___	O
Report):	O
There	O
is	O
hypoventilatory	O
change/atalectasis	O
within	O
the	O
posterior	O
aspects	O
of	O
the	O
lower	O
lobes.	O
Additionally	O
there	O
is	O
consolidative	O
opacity	O
with	O
air	O
bronchograms	O
identified	O
along	O
the	O
posterior	O
lateral	O
left	O
lung	O
base	O
extending	O
to	O
the	O
periphery.	O
This	O
may	O
represent	O
atalectasis	O
through	O
pneumonia	O
including	O
aspiration	O
etiology	O
cannot	O
be	O
excluded.	O
Partially	O
imaged	O
is	O
cholelithiasis.	O
PA/LAT	O
CXR	O
(___):	O
PA	O
and	O
lateral	O
upright	O
chest	O
radiographs	O
were	O
reviewed	O
with	O
no	O
prior	O
studies	O
available	O
for	O
comparison.There	O
is	O
a	O
normal	O
heart	O
size,	O
and	O
overall	O
normal	O
mediastinal	O
contour	O
is	O
demonstrated.	O
There	O
is	O
substantial	O
elevation	O
of	O
the	O
right	O
hemidiaphragm,	O
reason	O
unclear.	O
There	O
is	O
adjacent	O
opacity	O
at	O
least	O
in	O
part	O
representing	O
right	O
middle	O
lobe	O
atelectasis.	O
Although	O
no	O
definitive	O
right	O
hilar	O
mass	O
is	O
demonstrated,	O
it	O
cannot	O
be	O
entirely	O
excluded	O
and	O
correlation	O
with	O
chest	O
CT	O
would	O
be	O
recommended	O
on	O
a	O
non-emergency	O
basis.	O
The	O
appearance	O
of	O
the	O
thoracic	O
spine	O
is	O
unremarkable	O
within	O
the	O
limitations	O
of	O
the	O
study	O
technique.	O
___	O
X-RAY	O
SUPINE/UPRIGHT	O
(___):	O
There	O
is	O
elevation	O
of	O
the	O
right	O
hemidiaphragm,	O
also	O
seen	O
on	O
the	O
chest	O
radiograph	O
from	O
the	O
same	O
day.	O
The	O
lung	O
bases	O
appear	O
clear.	O
Nonspecific	O
non-dilated	O
loops	O
of	O
small	O
bowel	O
are	O
present.	O
There	O
is	O
a	O
moderate	O
amount	O
of	O
colonic	O
stool.	O
There	O
is	O
no	O
pneumoperitoneum.	O
EKG	O
(___):	O
Sinus	O
rhythm.	O
Borderline	O
low	O
voltage	O
in	O
the	O
limb	O
leads.	O
No	O
previous	O
tracing	O
available	O
for	O
comparison.	O
CT	O
CHEST	O
W	O
CONTRAST	O
(___):	O
1.	O
Filling	O
defects	O
in	O
the	O
right	O
main	O
pulmonary	O
artery	O
extending	O
into	O
the	O
upper	O
and	O
lower	O
lobar	O
pulmonary	O
arteries	O
consistent	O
with	O
nonocclusive	O
pulmonary	O
emboli.	O
No	O
CT	O
evidence	O
of	O
right	O
heart	O
strain.	O
2.	O
Elevation	O
of	O
the	O
right	O
hemidiaphragm	O
with	O
associated	O
right	O
lower	O
lobe	O
atelectasis/scarring	O
and	O
bronchiectasis	O
3.	O
Collapse	O
of	O
the	O
right	O
middle	O
lobe;	O
as	O
the	O
right	O
middle	O
lobe	O
is	O
collapsed	O
it	O
is	O
difficult	O
to	O
evaluate	O
for	O
an	O
underlying	O
mass,	O
but	O
airways	O
are	O
open	O
and	O
none	O
is	O
detected.	O
4.	O
Mild	O
emphysema	O
VIDEO	O
SWALLOW	O
EVAL	O
(___):	O
Barium	O
passes	O
freely	O
through	O
the	O
oropharynx	O
and	O
esophagus	O
without	O
evidence	O
of	O
obstruction.	O
There	O
was	O
1	O
episode	O
of	O
trace	O
penetration	O
with	O
thin	O
liquids	O
but	O
no	O
aspiration.	O
IMPRESSION:	O
There	O
was	O
a	O
trace	O
penetration	O
with	O
thin	O
liquids	O
but	O
no	O
aspiration.	O
PA/LAT	O
CXR	O
(___):	O
As	O
compared	O
to	O
the	O
previous	O
image,	O
the	O
pre-existing	O
elevation	O
of	O
the	O
right	O
hemidiaphragm	O
has	O
slightly	O
increased.	O
In	O
addition,	O
a	O
pre-existing	O
atelectasis	O
at	O
the	O
right	O
lung	O
base	O
is	O
also	O
more	O
extensive	O
than	O
seen	O
on	O
the	O
previous	O
image.	O
There	O
is	O
no	O
evidence	O
of	O
pleural	O
effusion	O
on	O
both	O
the	O
frontal	O
and	O
the	O
lateral	O
radiograph.	O
Both	O
the	O
atelectasis	O
and	O
the	O
elevation	O
of	O
the	O
hemidiaphragm	O
could	O
be	O
related	O
to	O
the	O
known	O
episode	O
of	O
pulmonary	O
embolism.	O
The	O
remaining	O
lung	O
is	O
unremarkable.	O
Normal	O
size	O
of	O
the	O
cardiac	O
silhouette.	O
No	O
pneumothorax.	O
CT	O
___	O
(___):	O
There	O
is	O
no	O
evidence	O
of	O
malignancy.	O
Brief	O
Hospital	O
Course:	O
This	O
is	O
a	O
___	O
year	O
old	O
single	O
man,	O
history	O
of	O
depression	O
with	O
psychotic	O
features,	O
recent	O
suicide	O
attempt,	O
s/p	O
failed	O
ECT	O
trials	O
who	O
presents	O
as	O
a	O
transfer	O
from	O
___	O
for	O
possible	O
ECT	O
treatment	O
s/p	O
recent	O
suicide	O
attempt	O
via	O
overdose	O
resulting	O
in	O
ICU	O
admission.	O
Patient's	O
history	O
significant	O
for	O
approximately	O
___	O
year	O
h/o	O
affective	O
unipolar	O
mood	O
disorder	O
with	O
psychosis	O
characterized	O
by	O
intense	O
somatic	O
preoccupation,	O
social	O
withdrawal,	O
significant	O
weight	B-Weight_loss
loss	B-Weight_loss
and	O
two	O
suicide	O
attempts	O
the	O
patient	O
could	O
not	O
clearly	O
describe	O
but	O
that	O
seem	O
to	O
be	O
related	O
to	O
his	O
somatic	O
preoccupation.	O
Differential	O
diagnosis	O
is	O
somewhat	O
broad,	O
but	O
etiology	O
seems	O
most	O
likely	O
secondary	O
to	O
a	O
psychotic	O
depression.	O
PSYCHIATRIC:	O
#.	O
Legal/Safety:	O
patient	O
admitted	O
on	O
___,	O
CV	O
signed	O
and	O
accepted.	O
Patient	O
maintained	O
safety	O
throughout	O
admission	O
on	O
15	O
minute	O
checks	O
#.	O
Depression:	O
as	O
above	O
with	O
psychotic	O
features	O
-	O
Medicine	O
and	O
anesthesia	O
consulted	O
and	O
cleared	O
the	O
patient	O
for	O
ECT.	O
Received	O
a	O
total	O
of	O
14	O
treatments	O
(9	O
bilateral),	O
which	O
were	O
converted	O
to	O
bilateral	O
ECT	O
starting	O
with	O
treatment	O
#5.	O
-	O
Remeron	O
was	O
increased	O
to	O
22.5	O
mg	O
po	O
qhs	O
on	O
___.	O
He	O
tolerated	O
this	O
increase	O
well	O
without	O
significant	O
side	O
effects.	O
-	O
Risperidone	O
was	O
increased	O
to	O
1	O
mg	O
po	O
bid	O
on	O
___.	O
He	O
tolerated	O
this	O
increase	O
well	O
without	O
significant	O
side	O
effects.	O
-	O
Venlafaxine	O
was	O
continued	O
at	O
75	O
mg	O
po	O
bid	O
with	O
meals.	O
-	O
Trazodone	O
was	O
continued	O
at	O
150	O
mg	O
po	O
qhs	O
+25	O
mg	O
po	O
prn	O
insomnia	O
-	O
Around	O
the	O
time	O
that	O
his	O
ECT	O
was	O
increased	O
to	O
bilateral	O
treatments,	O
he	O
began	O
to	O
show	O
evidence	O
of	O
significant	O
mood	O
improvement.	O
On	O
admission	O
he	O
had	O
intense	O
somatic	O
preoccupation	O
with	O
his	O
bowel	O
movements,	O
characterized	O
by	O
feelings	O
of	O
depression	O
on	O
days	O
when	O
he	O
was	O
constipated	O
and	O
a	O
rigid	O
inflexibility	O
wherein	O
he	O
felt	O
he	O
could	O
not	O
contract	O
for	O
safety	O
or	O
guarantee	O
that	O
he	O
would	O
not	O
attempt	O
suicide	O
in	O
the	O
future	O
if	O
his	O
constipation	O
persisted.	O
About	O
halfway	O
through	O
hospitalization,	O
he	O
became	O
more	O
flexible	O
and	O
less	O
preoccupied	O
around	O
this	O
somatic	O
complaint.	O
He	O
began	O
to	O
also	O
show	O
greater	O
range	O
of	O
affect	O
and	O
less	O
anhedonia.	O
By	O
discharge,	O
he	O
was	O
significantly	O
less	O
somatically	O
preoccupied	O
with	O
his	O
bowels,	O
endorsed	O
an	O
improved	O
mood	O
without	O
suicidal	O
thoughts,	O
and	O
was	O
future	O
oriented.	O
-	O
Discharge	O
diagnosis	O
was	O
depression	O
with	O
psychotic	O
features.	O
Psychosis	O
secondary	O
to	O
cognitive	O
decline	O
was	O
felt	O
unlikely	O
due	O
to	O
his	O
normal	O
performance	O
on	O
MOCA	O
(___),	O
unremarkable	O
full	O
neurologic	O
exam,	O
and	O
general	O
high	O
level	O
of	O
function	O
on	O
ADLs	O
at	O
baseline.	O
MEDICAL:	O
#.	O
PE:	O
on	O
___	O
patient	O
underwent	O
spiral	O
CT	O
to	O
follow-up	O
on	O
CXR/CT	O
that	O
showed	O
?atelectasis.	O
Radiology	O
report	O
revealed	O
incidental	O
finding	O
of	O
multiple	O
PE's	O
including	O
a	O
large	O
right	O
main	O
pulmonary	O
artery	O
embolus.	O
Medicine	O
and	O
Pulmonology	O
services	O
were	O
consulted.	O
Per	O
Pulm	O
recs,	O
the	O
patient	O
was	O
started	O
on	O
anticoagulation	O
with	O
Rivaroxiban	O
20mg	O
daily,	O
then	O
switched	O
to	O
Lovenox	O
(weight-based	O
protocol)	O
BID	O
while	O
receiving	O
ECT	O
--	O
chosen	O
for	O
its	O
reversible	O
properties.	O
On	O
completion	O
of	O
ECT,	O
he	O
was	O
switched	O
back	O
to	O
Rivaroxiban	O
(dose	O
20mg	O
daily).	O
Will	O
need	O
to	O
complete	O
at	O
least	O
3	O
month	O
course	O
of	O
anticoagulation.	O
He	O
will	O
follow	O
up	O
with	O
Pulm	O
as	O
outpatient	O
___	O
weeks	O
following	O
initial	O
diagnosis	O
(date	O
of	O
follow	O
up	O
___	O
and	O
will	O
need	O
repeat	O
chest	O
CT	O
with	O
contrast	O
on	O
that	O
date.	O
Of	O
note	O
there	O
is	O
concern	O
for	O
possible	O
lung	O
mass	O
underlying	O
the	O
significant	O
atalectasis	O
seen	O
on	O
CT,	O
which	O
will	O
be	O
investigated	O
on	O
the	O
repeat	O
chest	O
CT.	O
Given	O
patient's	O
smoking	O
history	O
and	O
unintentional	O
40	O
pound	O
weight	B-Weight_loss
loss	B-Weight_loss
over	O
the	O
past	O
___	O
years,	O
cancer	O
is	O
of	O
particular	O
concern.	O
Video	O
swallow	O
was	O
negative	O
for	O
aspirtation.	O
For	O
full	O
neoplastic	O
workup,	O
CT	O
abdomen	O
was	O
also	O
performed	O
in	O
hospital,	O
showing	O
no	O
evidence	O
of	O
neoplasm.	O
#.	O
COPD:	O
stable	O
during	O
this	O
admission	O
-	O
Continued	O
patient's	O
home	O
Advair	O
250/50	O
1	O
puff	O
bid.	O
This	O
was	O
increased	O
to	O
500/50	O
with	O
improvement	O
in	O
symptoms.	O
-	O
Added	O
Duonebs	O
inh	O
q6hrs	O
PRN,	O
with	O
additional	O
doses	O
given	O
on	O
ECT	O
days	O
#.	O
HTN:	O
stable	O
during	O
this	O
admission	O
-	O
continued	O
home	O
lisinopril	O
#.	O
Bowel	O
issues:	O
likely	O
related	O
to	O
depression	O
-	O
Continued	O
home	O
stool	O
softeners	O
and	O
added	O
Metamucil	O
wafers.	O
-	O
Reported	O
improved	O
symptoms	O
with	O
ECT.	O
CONTACTS:	O
Psychiatrist	O
=	O
___	O
(phone	O
___	O
PCP	O
=	O
___	O
(phone	O
#	O
___	O
Brother	O
(HCP)	O
=	O
___	O
(work	O
#	O
___,	O
cell	O
#	O
___	O
Sister	O
in	O
law	O
=	O
___	O
(phone	O
#	O
___	O
Pharmacy	O
=	O
___	O
(phone	O
#	O
___	O
Risk	O
Assessment:	O
Patient	O
is	O
at	O
elevated	O
chronic	O
risk	O
for	O
suicide	O
given	O
chronic	O
severe	O
depression,	O
chronic	O
medical	O
illness,	O
hx	O
of	O
suicide	O
attempts,	O
and	O
demographics.	O
His	O
risk	O
was	O
modified	O
during	O
hospialization	O
with	O
ECT	O
and	O
medication	O
changes	O
with	O
improvement	O
in	O
depressive	O
symptoms	O
and	O
resolution	O
of	O
suicidality,	O
supportive	O
psychotherapy,	O
and	O
with	O
procurement	O
of	O
outpatient	O
treaters.	O
Protective	O
factors	O
include	O
a	O
supportive	O
family,	O
future	O
orientation,	O
and	O
absence	O
of	O
current	O
suicidality.	O
At	O
this	O
point	O
in	O
time	O
with	O
the	O
available	O
evidence,	O
patient	O
is	O
not	O
at	O
imminent	O
risk	O
of	O
harm	O
to	O
self	O
and	O
can	O
be	O
discharged	O
with	O
outpatient	O
followup.	O
Medications	O
on	O
Admission:	O
HOME	O
MEDICATION	O
LIST	O
(from	O
prior	O
to	O
initial	O
hospitalization):	O
-	O
Clonazepam	O
0.5mg	O
qAM	O
+	O
1mg	O
qHS	O
(last	O
filled	O
___	O
-	O
Trazodone	O
HCl	O
25mg	O
HS	O
(last	O
filled	O
___	O
-	O
Methylphenidate	O
10mg	O
daily	O
(last	O
filled	O
___	O
-	O
Lisinopril	O
2.5mg	O
daily	O
(last	O
filled	O
___	O
-	O
Pantoprazole	O
40mg	O
qAM	O
(before	O
breakfast)	O
-	O
Thiamine	O
HCl	O
(vitamin	O
B1)	O
100mg	O
daily	O
(last	O
filled	O
___	O
-	O
Mirtazapine	O
30mg	O
HS	O
(last	O
filled	O
___	O
-	O
Olanzapine	O
7.5mg	O
daily	O
(last	O
filled	O
___,	O
started	O
___	O
-	O
Sertraline	O
100mg	O
daily	O
(took	O
for	O
2	O
weeks	O
in	O
___	O
-	O
Simvastatin	O
20mg	O
daily	O
(last	O
filled	O
___	O
MEDS	O
ON	O
TRANSFER:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Mirtazapine	O
15	O
mg	O
PO	O
HS	O
2.	O
RISperidone	O
1	O
mg	O
PO	O
HS	O
3.	O
RISperidone	O
0.5	O
mg	O
PO	O
DAILY	O
4.	O
RISperidone	O
0.25	O
mg	O
PO	O
Q1H	O
PRN	O
agitation	O
5.	O
TraZODone	O
150	O
mg	O
PO	O
HS	O
6.	O
TraZODone	O
25	O
mg	O
PO	O
HS:PRN	O
insomnia	O
7.	O
Venlafaxine	O
75	O
mg	O
PO	O
BID	O
8.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
HS	O
9.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
10.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
pain,	O
fever	O
11.	O
Aluminum-Magnesium	O
Hydrox.-Simethicone	O
30	O
mL	O
PO	O
QID:PRN	O
upset	O
stomach	O
12.	O
Bisacodyl	O
5	O
mg	O
PO	O
DAILY:PRN	O
constiaption	B-Constipation
13.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
DAILY:PRN	O
constiaption	B-Constipation
14.	O
Senna	O
8.6	O
mg	O
PO	O
BID:PRN	O
constipation	B-Constipation
15.	O
Fluticasone-Salmeterol	O
Diskus	O
(250/50)	O
1	O
INH	O
IH	O
BID	O
16.	O
Fleet	O
Enema	O
___AILY:PRN	O
constipation	B-Constipation
Discharge	O
Medications:	O
1.	O
Bisacodyl	O
10	O
mg	O
PO/PR	O
DAILY:PRN	O
constipation	O
RX	O
*bisacodyl	O
[Laxative]	O
5	O
mg	O
2	O
tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
2.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID:PRN	O
constipation	O
RX	O
*docusate	O
sodium	O
100	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*30	O
Capsule	O
Refills:*0	O
3.	O
Mirtazapine	O
22.5	O
mg	O
PO	O
HS	O
RX	O
*mirtazapine	O
15	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
at	O
bedtime	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
RX	O
*mirtazapine	O
7.5	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
at	O
bedtime	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
4.	O
RISperidone	O
1	O
mg	O
PO	O
QAM	O
RX	O
*risperidone	O
[Risperdal]	O
1	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
in	O
the	O
morning	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
5.	O
RISperidone	O
1	O
mg	O
PO	O
HS	O
RX	O
*risperidone	O
[Risperdal]	O
1	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
at	O
bedtime	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
6.	O
Venlafaxine	O
75	O
mg	O
PO	O
BIDWM	O
RX	O
*venlafaxine	O
75	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
twice	O
a	O
day	O
with	O
meals	O
Disp	O
#*60	O
Tablet	O
Refills:*0	O
7.	O
Milk	O
of	O
Magnesia	O
30	O
ml	O
PO	O
Q8H:PRN	O
constipation	O
RX	O
*magnesium	O
hydroxide	O
[Milk	O
of	O
Magnesia]	O
400	O
mg/5	O
mL	O
30	O
ml	O
by	O
mouth	O
every	O
eight	O
(8)	O
hours	O
Refills:*0	O
8.	O
Psyllium	O
Wafer	O
1	O
WAF	O
PO	O
DAILY	O
RX	O
*psyllium	O
[Metamucil]	O
1.7	O
g	O
1	O
wafer(s)	O
by	O
mouth	O
once	O
a	O
day	O
Disp	O
#*30	O
Wafer	O
Refills:*0	O
9.	O
Tiotropium	O
Bromide	O
1	O
CAP	O
IH	O
DAILY	O
RX	O
*tiotropium	O
bromide	O
[Spiriva	O
with	O
HandiHaler]	O
18	O
mcg	O
1	O
cap	O
inhalation	O
once	O
a	O
day	O
in	O
the	O
morning	O
Disp	O
#*30	O
Capsule	O
Refills:*0	O
10.	O
Pantoprazole	O
40	O
mg	O
PO	O
QAM	O
RX	O
*pantoprazole	O
[Protonix]	O
40	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
11.	O
TraZODone	O
50	O
mg	O
PO	O
HS:PRN	O
insomnia	O
RX	O
*trazodone	O
50	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
at	O
bedtime	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
12.	O
Fluticasone-Salmeterol	O
Diskus	O
(500/50)	O
1	O
INH	O
IH	O
BID	O
RX	O
*fluticasone-salmeterol	O
[Advair	O
Diskus]	O
500	O
mcg-50	O
mcg/Dose	O
1	O
puff	O
inhaled	O
twice	O
a	O
day	O
Disp	O
#*30	O
Disk	O
Refills:*0	O
13.	O
TraZODone	O
150	O
mg	O
PO	O
HS	O
RX	O
*trazodone	O
150	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
at	O
bedtime	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
14.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
HS	O
RX	O
*tamsulosin	O
0.4	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
at	O
bedtime	O
Disp	O
#*30	O
Capsule	O
Refills:*0	O
15.	O
Rivaroxaban	O
20	O
mg	O
PO/NG	O
DAILY	O
RX	O
*rivaroxaban	O
[Xarelto]	O
20	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
16.	O
Psyllium	O
1	O
PKT	O
PO	O
TID:PRN	O
constipation	O
RX	O
*psyllium	O
1	O
packet(s)	O
by	O
mouth	O
three	O
times	O
a	O
day	O
Disp	O
#*45	O
Packet	O
Refills:*0	O
17.	O
Aluminum-Magnesium	O
Hydrox.-Simethicone	O
30	O
mL	O
PO	O
QID:PRN	O
upset	O
stomach	O
18.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
pain,	O
fever	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Depression	O
with	O
psychotic	O
features	O
PE,	O
COPD	O
Discharge	O
Condition:	O
-	O
Appearance:	O
pleasant,	O
elderly	O
male.	O
-	O
behavior:	O
cooperative	O
with	O
interview,	O
makes	O
some	O
eye	O
contact	O
-	O
Mood	O
and	O
Affect:	O
'better'/	O
constricted	O
-	O
Thought	O
process:	O
linear	O
and	O
concrete	O
-	O
Thought	O
Content:	O
no	O
overt	O
delusions	O
or	O
paranoid	O
ideation.	O
No	O
hallucinations.	O
Denies	O
current	O
SI	O
or	O
HI.	O
-	O
Judgment/Insight:	O
poor/improving	O
-	O
Speech:	O
no	O
dysarthria	O
or	O
paraphasias.	O
Monotonous	O
and	O
low	O
volume	O
voice	O
-	O
Language:	O
fluent	O
___	O
speaker	O
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
You	O
were	O
admitted	O
to	O
the	O
___	O
inpatient	O
psychiatry	O
unit	O
for	O
worsening	O
depression	O
and	O
several	O
recent	O
suicide	O
attempts.	O
We	O
made	O
some	O
changes	O
to	O
your	O
medications	O
and	O
treated	O
you	O
with	O
ECT	O
(electro-convulsive	O
therapy).	O
While	O
in	O
the	O
hospital	O
you	O
were	O
found	O
to	O
have	O
a	O
pulmonary	O
embolism	O
(blood	O
clot	O
in	O
the	O
lungs)	O
which	O
was	O
treated	O
with	O
blood	O
thinning	O
medications.	O
Your	O
depression	O
improved	O
significantly	O
in	O
the	O
hospital.	O
You	O
will	O
need	O
to	O
follow	O
up	O
closely	O
with	O
Psychiatry,	O
your	O
Primary	O
Care	O
doctor,	O
and	O
Pulmonology	O
(lung	O
specialists)	O
after	O
discharge.	O
See	O
below	O
for	O
appointment	O
information.	O
Followup	O
Instructions:	O
___	O

